Literature DB >> 9582188

Genetic studies in the sleep disorder narcolepsy.

H Kadotani1, J Faraco, E Mignot.   

Abstract

Narcolepsy is a chronic neurologic disorder characterized by excessive daytime sleepiness and abnormal manifestations of REM sleep including cataplexy, sleep paralysis, and hypnagogic hallucinations. Narcolepsy is both a significant medical problem and a unique disease model for the study of sleep. Research in human narcolepsy has led to the identification of specific HLA alleles (DQB1*0602 and DQA1*0102) that predispose to the disorder. This has suggested the possibility that narcolepsy may be an autoimmune disorder, a hypothesis that has not been confirmed to date. Genetic factors other than HLA are also likely to be involved. In a canine model of narcolepsy, the disorder is transmitted as a non-MHC single autosomal recessive trait with full penetrance (canarc-1). A tightly linked marker for canarc-1 has been identified, and positional cloning studies are under way to isolate canarc-1 from a newly developed canine genomic BAC library. The molecular cloning of this gene may lead to a better understanding of sleep mechanisms, as has been the case for circadian rhythms following the cloning of frq, per, and Clock.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9582188     DOI: 10.1101/gr.8.5.427

Source DB:  PubMed          Journal:  Genome Res        ISSN: 1088-9051            Impact factor:   9.043


  9 in total

Review 1.  Narcolepsy: immunological aspects.

Authors:  Sebastiaan Overeem; John Logan Black; Gert Jan Lammers
Journal:  Sleep Med Rev       Date:  2008-03-04       Impact factor: 11.609

2.  HLA-DQ polymorphism influences progression of demyelination and neurologic deficits in a viral model of multiple sclerosis.

Authors:  K D Pavelko; K M Drescher; D B McGavern; C S David; M Rodriguez
Journal:  Mol Cell Neurosci       Date:  2000-06       Impact factor: 4.314

Review 3.  Orexin (hypocretin) receptor agonists and antagonists for treatment of sleep disorders. Rationale for development and current status.

Authors:  Michihiro Mieda; Takeshi Sakurai
Journal:  CNS Drugs       Date:  2013-02       Impact factor: 5.749

4.  Isolated cataplexy in the differential diagnosis of drop attacks: a case of successful clinical diagnosis and treatment.

Authors:  Robert T Egel; Anthony Lee; Thomas Bump; Alexander Javois
Journal:  Case Rep Neurol Med       Date:  2012-07-17

Review 5.  History of narcolepsy at Stanford University.

Authors:  Emmanuel J M Mignot
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

6.  Characterization of the major histocompatibility complex class II DOB, DPB1, and DQB1 alleles in cynomolgus macaques of Vietnamese origin.

Authors:  Fei Ling; Li-qiong Wei; Tao Wang; Hai-bo Wang; Min Zhuo; Hong-li Du; Ju-fang Wang; Xiao-ning Wang
Journal:  Immunogenetics       Date:  2010-12-04       Impact factor: 2.846

7.  The association between narcolepsy during pregnancy and maternal-fetal risk factors/outcomes.

Authors:  Annise Wilson; Deepa Dongarwar; Krystal Carter; Maricarmen Marroquin; Hamisu M Salihu
Journal:  Sleep Sci       Date:  2022 Jul-Sep

8.  Role of orexin in modulating arousal, feeding, and motivation.

Authors:  Natsuko Tsujino; Takeshi Sakurai
Journal:  Front Behav Neurosci       Date:  2013-04-18       Impact factor: 3.558

9.  Association of narcolepsy-cataplexy with HLA-DRB1 and DQB1 in Mexican patients: a relationship between HLA and gender is suggested.

Authors:  Carmen Alaez; Ling Lin; Hilario Flores-A; Miriam Vazquez; Andrea Munguia; Emmanuel Mignot; Reyes Haro; Harry Baker; Clara Gorodezky
Journal:  BMC Med Genet       Date:  2008-08-15       Impact factor: 2.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.